Skip to main content
HairCited

Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.

Nermeen Ibrahim Bedair, Alaa Safwat Abdelaziz, Fatemaalzahraa Saad Abdelrazik, Mohamed El-Kassas, Mohamed Hussein AbouHadeed
Other Archives of dermatological research 2024 5 citations
PubMed DOI CC-BY PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D38844670'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Case-control
Taille de l'échantillon
100
Intervention
Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study. None
Comparateur
Placebo
Direction de l'effet
Mixed
Risque de biais
Moderate

Abstract

Telogen effluvium is characterized by excessive hair shedding usually following a stressful event. Ferritin has been used in clinical practice as a biomarker of nonanemic iron deficiency in cases of telogen effluvium. During the years of the COVID19 pandemic, telogen effluvium was reported as a part of post covid manifestations. As ferritin was also a biomarker for inflammation in cases with covid infection, this study was designed to evaluate the value of ferritin in cases with postcovid telogen effluvium one hundred patients recovering from covid 19 for 4-12 weeks were included in the study, detailed drug and laboratory history was obtained and serum ferritin level was measured. the mean serum level of ferritin among telogen effluvium patients was significantly lower than controls (68.52 ± 126 and 137 ± 137.597 ug/L respectively). Patients with telogen effluvium used significantly more azithromycin and ivermectin and significantly less vitamin C, D, lactoferrin and zinc than the controls Although serum ferritin is lower among telogen effluvium patients, it was still higher than the cutoff value for diagnosing nonanemic iron deficiency, we suggest that it will not be a good biomarkers in these cases. Our secondary outcomes showed that dietary supplements used during active infection such as vitamin C, D, lactoferrin and zinc might have a preventive value on postcovid hair loss, while azithromycin and ivermectin could have a negative long term effect on telogen effluvium.

Full Text

PDF
Loading PDF...

Figures

Tables

Table 1

GroupX2P-value
Hair fall N = 50Control N = 50
GenderFemale48 (96%)31 (62%)17.42< 0.0001
Male2 (4%)19 (38%)
AgeMean ± SD27.64 ± 6.0433.84 ± 8.684.14< 0.0001
Median2732
Min- Max18–4518–55
Duration since diagnosis (Weeks)Mean ± SD13.10 ± 5.7612.92 ± 6.150.1510.880
Median1213
Range4–284–24

Table 2

GroupP-value
Hair fall N = 50Control N = 50
AzithromycinNo13 (26%)35 (70%)< 0.0001
Yes37 (74%)15 (30%)
IvermectinNo24 (48%)38 (76%)0.004
Yes26 (52%)12 (24%)
Paracetamol50 (100%)50 (100%)-
Vit-CNo36 (72%)15 (30%)< 0.0001
Yes14 (28.0%)35 (70%)
Vit-DNo48 (96%)36 (72%)0.001
Yes2 (4%)14 (28%)
ZincNo33 (66%)8 (16%)< 0.0001
Yes17 (34%)42 (84%)
LactoferrinNo44 (88.0%)21 (42%)< 0.0001
Yes6 (12%)29 (58%)

References

  1. Telogen effluvium Indian J Dermatol Venereol Leprol, 2013
  2. Iron status in diffuse telogen hair loss among women Acta Dermatovenerol Croat, 2009
  3. Low iron stores: a risk factor for excessive hair loss in non-menopausal women Eur J Dermatol, 2007
  4. Serum ferritin and vitamin D in female hair loss: do they play a role? Skin Pharmacol Physiol, 2013
  5. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action Mol Psychiatry, 2023
  6. Time of onset and duration of post-COVID-19 acute telogen effluvium J Am Acad Dermatol, 2021
  7. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis PLoS ONE, 2021
  8. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases Biomarkers, 2020
  9. Adjusting thresholds of serum ferritin for iron deficiency: a moving target☆ Rev Bras Hematol Hemoter, 2017
  10. Effect of ferritin, INR, and D-dimer immunological parameters levels as predictors of COVID-19 mortality: a strong prediction with the decision trees Heliyon, 2023
  11. The Diagnostic Value of Serum Ferritin for Telogen Effluvium: a cross-sectional comparative study Clin Cosmet Investig Dermatol, 2021
  12. Untitled
  13. Characteristics of telogen effluvium in COVID-19 in western Iran (2020) Bras Dermatol, 2021
  14. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity J Med Life, 2022
  15. SARS-CoV-2 Infection-A trigger factor for Telogen Effluvium: review of the literature with a case-based Guidance for clinical evaluation Life (Basel), 2023
  16. Post-SARS-CoV-2 Acute Telogen Effluvium: an expected complication J Clin Med, 2022
  17. SARS‐CoV‐2‐induced telogen effluvium: a multicentric study J Eur Acad Dermatol Venereol, 2021
  18. COVID-19 induced telogen effluvium Dermatol Ther, 2021
  19. Telogen effluvium after SARS-CoV-2 infection: a series of cases and possible pathogenetic mechanisms Skin Appendage Disord, 2021
  20. Untitled
  21. Telogen effluvium related to post severe Sars-Cov‐2 infection: clinical aspects and our management experience Dermatol Ther, 2021
  22. Acute telogen effluvium related to COVID-19 infection: a review J Pakistan Association Dermatologists, 2022
  23. Untitled
  24. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs Turk J Med Sci, 2020
  25. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles Br J Dermatol, 2005
  26. Untitled
  27. COVID-19 cytokine storm: the interplay between inflammation and coagulation Lancet Respir Med, 2020
  28. The Effect of Ferritin, vitamin D, and some hormonal and biochemical parameters on patients with female-pattern hair loss after COVID-19 infection J Prev Diagn Treat Strategies Med, 2023
  29. Evaluation of patients with telogen effluvium during the pandemic: may the monocytes be responsible for post COVID-19 telogen effluvium? J Cosmet Dermatol, 2022
  30. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women Clin Endocrinol (Oxf), 1992
  31. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups J Am Acad Dermatol, 2010
  32. Iron status and haematological changes in adolescent female inpatients with anorexia nervosa J Paediatr Child Health, 2004
  33. Ferritin – from iron, through inflammation and autoimmunity, to COVID-19 J Autoimmun, 2022
  34. Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle Br J Dermatol, 1994
  35. The role of vitamins and minerals in Hair loss: a review Dermatol Ther (Heidelb), 2019
  36. Symptom Profile of patients with Post-COVID-19 conditions and influencing factors for recovery J Clin Med Res, 2023
  37. The effect of tripeptide-copper complex on human hair growth in vitro Arch Pharm Res, 2007
  38. Analysis of serum zinc and copper concentrations in hair loss Ann Dermatol, 2013
  39. Lactoferrin as potential preventative and adjunct treatment for COVID-19 Int J Antimicrob Agents, 2020
  40. Complementary strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium Clin Cosmet Investig Dermatol, 2022
  41. Lactoferrin promotes hair growth in mice and increases dermal papilla cell proliferation through Erk/Akt and wnt signaling pathways Arch Dermatol Res, 2019
  42. Untitled
  43. Telogen effluvium associated with COVID-19 infection Dermatol Ther, 2021
  44. Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: a targeted screen in the zebrafish lateral line Front Cell Neurosci, 2022

Used In Evidence Reviews

Similar Papers